Province Expands the Use of Biosimilars to Improve the Sustainability of Public Drug Plans

 Province Expands the Use of Biosimilars to Improve the Sustainability of Public Drug Plans

Province Expands the Use of Biosimilars to Improve the Sustainability of Public Drug Plans

Shots:

  • The provincial government is improving the sustainability of its public drug plans by expanding the use of biosimilars
  • This initiative follows similar policies implemented by British Columbia and Alberta over the past 2yrs., where 10,000 of patients in each province were safely switched from an originator biologic drug to a biosimilar
  • The initiative allows the government to fund new drugs as switching to biosimilar results in savings. The province’s plans to provide subsidized drug coverage for about 135,000 people while in 2019-20, the province invested about $220M in these drug plans

Click here to­ read full press release/ article | Ref: Biosimilars | Image: Twitter

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post